Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 48 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

8 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

22 recruiting1 with results

Enrollment Performance

Analytics

N/A

11(40.7%)

Phase 4

6(22.2%)

Phase 2

5(18.5%)

Phase 1

2(7.4%)

Phase 3

2(7.4%)

Early Phase 1

1(3.7%)

27Total

N/A(11)

Phase 4(6)

Phase 2(5)

Phase 1(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (48)

Showing 20 of 48 trials

NCT06902740Phase 4Recruiting

PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

Role: collaborator

NCT06711016Not ApplicableRecruiting

Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR

Role: collaborator

NCT07632677Recruiting

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Role: collaborator

NCT07167342Phase 4Recruiting

The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma

Role: collaborator

NCT07413068Recruiting

Treatment Outcomes and Complications of Three Therapeutic Approaches for Concomitant Choledocholithiasis and Cholecystolithiasis

Role: collaborator

NCT07495111Not ApplicableRecruiting

Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis

Role: collaborator

NCT07496177Phase 2Not Yet Recruiting

A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.

Role: collaborator

NCT07466251Phase 4Not Yet Recruiting

PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke

Role: collaborator

NCT07444099Not ApplicableEnrolling By Invitation

Early Postoperative Intervention in Gastric Cancer Patients

Role: collaborator

NCT07402135Not ApplicableNot Yet Recruiting

Fecal Noninvasive Biomarkers Oriented Control Versus Usual Care Strategy in Ulcerative Colitis

Role: collaborator

NCT07379255Recruiting

Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.

Role: collaborator

NCT07379281Recruiting

Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology

Role: collaborator

NCT07379268Recruiting

Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.

Role: collaborator

NCT06462313Not ApplicableCompleted

Dobutamine for Management of Surgical Patients With Septic Shock

Role: collaborator

NCT05896826Recruiting

Magnetocardiography in the Accurate Identification of Myocardial Infarction

Role: collaborator

NCT06197724Recruiting

MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT07152886Phase 4Not Yet Recruiting

The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer

Role: collaborator

NCT06014996Not ApplicableCompleted

InsightPFA Trial of the LotosPFA Catheter

Role: collaborator

NCT05979935Active Not Recruiting

A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in Cirrhosis

Role: collaborator